ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JOSHUA MEADOR D.O.

5125 SKYLINE RD S KAISER FOUNDATION HEALTH PLAN OF NW

Salem | Oregon | 97306

(503) 361-5400

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,486Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1155

$531K Total Retail Price of All Prescriptions

Rank: 40 out of 1155

692 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 692 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

19% of this provider’s 692 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,425 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 649 608 1 3
LISINOPRIL 488 445 2 1
OMEPRAZOLE 451 418 3 5
ATENOLOL 390 366 4 10
HYDROCODONE-ACETAMINOPHEN 350 315 S3 5 4
METFORMIN HCL 341 312 6 7
LEVOTHROID 322 307 7 58
LOSARTAN POTASSIUM 251 240 8 18
HYDROCHLOROTHIAZIDE 237 216 9 9
AMLODIPINE BESYLATE 236 229 10 6
FUROSEMIDE 236 218 10 8
K-TAB 210 207 12 62
GLIPIZIDE 174 160 13 44
LEVOTHYROXINE SODIUM 169 159 14 2
WARFARIN SODIUM 158 151 15 11
ATORVASTATIN CALCIUM 143 123 16 12
FAMOTIDINE 142 133 17 76
ALENDRONATE SODIUM 139 139 18 25
MORPHINE SULFATE ER 139 100 S2 18 36
NORTRIPTYLINE HCL 135 117 20 112
TRAZODONE HCL 131 96 21 22
SERTRALINE HCL 129 101 22 24
METOPROLOL TARTRATE 120 120 23 14
FLUTICASONE PROPIONATE 116 105 24 37
PRAVASTATIN SODIUM 114 109 25 20
INSULIN SYRINGE 109 88 26 90
CITALOPRAM HBR 107 95 27 19
ACETAMINOPHEN-CODEINE 104 102 S3 28 101
GABAPENTIN 103 85 29 15
ADACEL 101 96 30 86
OXYCODONE-ACETAMINOPHEN 96 93 S2 31 45
OXYCODONE HCL 95 54 S2 32 23
PROAIR HFA 93 85 33 31
NAMENDA 91 91 34 67
TRIAMTERENE-HYDROCHLOROTHIAZID 83 80 35 89
NOVOLIN N 80 73 36 134
PAROXETINE HCL 79 79 37 48
TAMSULOSIN HCL 78 73 38 27
NOVOLIN R 76 68 39 165
DONEPEZIL HCL 74 72 40 41
FLUOXETINE HCL 74 50 40 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 72 42 26
ATROVENT HFA 70 65 43 175
ALLOPURINOL 69 68 44 29
NOVOLIN 70-30 60 58 45 183
DILT-XR 60 56 45 186
CIPROFLOXACIN HCL 57 51 47 72
CLOPIDOGREL 56 46 48 70
LANTUS 56 48 48 39
FENTANYL 53 18 S2 50 64
QVAR 52 48 51 149
NIFEDIPINE ER 52 41 51 189
ZOSTAVAX 51 44 53 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.